Betamethason/Calcipotriol (CRE)_TK, HEK, hkk

TENDER DESCRIPTION

The health insurance funds pursue the objective of concluding discount contracts pursuant to Section 130a(8) of SGB V with all suitable pharmaceutical companies for the active ingredients, active ingredient combinations and/or dosage forms, strengths or finished medicinal products specified in the respective lot. The following active ingredients, active ingredient combinations and/or dosage forms, strengths or finished medicinal products form part of the present procedure (for details, see information provided in the respective lot title): Betamethasone/Calcipotriol (CRE) Clobazam (liquid oral dosage form) Clotrimazole (Rx: vaginal dosage form) Mercaptopurine (FAM: solid oral dosage form) Methyldopa (250 mg (N3)) Nilotinib (excluding oral administration dispersed in apple purée) Nilotinib (including oral administration dispersed in apple purée) Oxybutynin (PFT) Perindopril erbumine/Indapamide (90 units) Perindopril/Indapamide (excluding Perindopril erbumine) Piribedil Pomalidomide Raltegravir (excluding GSE, KTA) Risperidone (solid oral dosage form: 0.25 mg) Tranylcypromine Oxybutynin (LIV) The health insurance funds pursue the objective of concluding discount contracts pursuant…

TENDER BRIEF

TENDER DOCUMENTS